Characterising methamphetamine/amphetamine use among opioid agonist therapy‐seeking adults with prescription‐type opioid use disorder in Canada

Ähnliche Einträge

• Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada
  von: Jenna Langlois, et al.
  Veröffentlicht: (2024)
• Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in Victoria, Australia, 2015 to 2023
  von: Joshua Dawe, et al.
  Veröffentlicht: (2025)
• Determinants of psychological distress during the COVID‐19 pandemic among people who use drugs in Montreal, Canada
  von: Iuliia Makarenko, et al.
  Veröffentlicht: (2024)
• Health utility among people who regularly use opioids in Australia
  von: Anh Dam Tran, et al.
  Veröffentlicht: (2024)
• It is not just opioids!
  von: Robert Kent
  Veröffentlicht: (2025)